Table 2 from Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus

Kinfe G. Bishu; Andrew D. Schreiner; Nicholas Shungu; Vanessa Diaz; Macelyn Batten; Mulugeta Gebregziabher

doi:10.1158/2767-9764.29757224

August 1, 2025

Table 2 from Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus

View Full Paper

Ask AI

Bookmark

Share

Key Points

Glycemic control is significantly associated with prostate cancer mortality among male veterans with type 2 diabetes.
The study utilizes competing risk models to analyze mortality outcomes related to glycemic levels over time.
Findings indicate that better glycemic control may reduce the risk of prostate cancer mortality in the veteran population.
Understanding this relationship may help guide treatment strategies for veterans with type 2 diabetes.

Implication

Cause-specific risk models reveal the link between glycemic control and prostate cancer mortality in veterans, suggesting clinical implications.

Abstract

Cause-specific competing risk models for the association between time-updated glycemic control and prostate cancer mortality in male veterans with type 2 diabetes (with TVC)

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bishu et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d032f https://doi.org/10.1158/2767-9764.29757224

View Full Paper

Ask AI

Bookmark

Share

Table 2 from Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus

Key Points

Implication

Abstract

Discussion

Cite This Study

Table 2 from Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading